1. A.H. Soloway, W. Tjarks, B.A. Barnum, F.-G. Rong, R.F. Barth, I.M. Codogni, and J.G. Wilson, “The chemistry of neutron capture therapy”, Chem. Rev., 98:1515–1562, 1998.
2. R.M. Brugger, S. Gibb, J.-L. Shih, S. Pickup, X. Luo, J. Oro, and B. Laster, Estimated doses by gadolinium neutron capture therapy, “Topics in Dosimetry & Treatment Planning for Neutron Capture Therapy”, R.G. Zamenhof, G.R. Solares, and O.K. Harling, ed., Advanced Medical Publications, Madison, Wisconsin, 1994.
3. M.A. Meyer, R.M. Brugger, J.C. Lattimer, K. Kutikkad, A.R. Schoone, and G. Ehrhardt, Non-invasive quantification of Gd uptake in tumors, in “Frontiers in Neutron Capture Therapy,” M.F. Hawthorne, K. Shelly, R.W. Wiersema, eds., Kluwer Academic/Plenum Publishers, New York, 2001, pp. 923–931.
4. B. Laster, S. Kahl, J. Kirz, L. Warkentein, S. Wirrick, and G. Shani, Receptor-mediated deliver of In and Gd into the tumor cell nucleus by BOPP”, Program and Abstracts of the Eighth International Symposium on NCT for Cancer, La Jolla, CA, 1998, p. 31.
5. S.W. Young, F. Qing, A. Harriman, J.L. Sessler, W.C. Dow, T.D. Mody, G.W. Hemmi, Y. Hao, and R.A. Miller, Gadolinium(III) texaphyrin: A tumor selective radiation sensitizer that is detectable by MRI, Proc. Natl. Acad. Sci. USA, 936:610–615, 1996, Medical Science.